Furthermore, the significant decrease in NOD1 expression observed in the treated groups, albeit still higher than the control, indicates the potential of MSCs and their conditioned media to modulate NOD1-mediated inflammatory pathways, which warrants further investigation in the context of CD pathogenesis. The gene discussed is NOD1; the disease is Cowden disease.